Novel transcript antisense to ARAF (ENSG00000289890)

Novel transcript, antisense to ARAF" (ENSG00000289890) refers to a long non-coding RNA transcribed in the antisense orientation relative to the ARAF protein-coding gene. Natural antisense transcripts (NATs) are endogenous RNAs that typically do not encode proteins but can regulate the expression or stability of overlapping genes through mechanisms such as transcriptional interference, RNA masking, double-stranded RNA formation, and chromatin remodeling[1][2][3]. While NATs are increasingly recognized as regulators of gene expression and implicated broadly across diseases—including cancer and neurological disorders—there is no current evidence that this particular antisense transcript has a direct role as a therapeutic target, disease biomarker, or is associated with any specific function or pathology[1][3]. Therefore, this entity should not be considered a canonical molecular target in the classical sense. Limitations: This target is a non-coding transcript, not a protein or "receptor," and may not have a validated biological or therapeutic role. Structured information such as canonical name or known aliases is limited; its main identifier is the Ensembl ID ENSG00000289890. Synopsis: ENSG00000289890 is an annotated long non-coding RNA antisense to ARAF, likely involved in gene regulation but not recognized as a classic biomedical target, with no known drug interactions or direct clinical utility[1][2][3].

Other names

NAT antisense to ARAFENSG00000289890